Skip to main content

Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  198.51
-0.28 (-0.14%)
AAPL  260.59
+4.81 (1.88%)
AMD  197.86
-9.46 (-4.56%)
BAC  53.17
+0.62 (1.19%)
GOOG  299.08
-6.94 (-2.27%)
META  633.74
-6.03 (-0.94%)
MSFT  397.05
-4.27 (-1.06%)
NVDA  180.68
-2.13 (-1.16%)
ORCL  153.80
-6.34 (-3.96%)
TSLA  402.58
-14.86 (-3.56%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.